Canadian High Income Equity Fund (the "Fund") (TSX:CIQ.UN) is pleased to
announce that it has initiated a distribution reinvestment plan ("DRIP") that is
available beginning with the June 30, 2014 record date. The DRIP provides
unitholders with the ability to automatically reinvest distributions and realize
the benefits of compound growth. Under the DRIP, if the 10 day weighted average
trading price prior to the distribution payment date (the "Trading Price") is
higher than the net asset value per unit ("NAV"), such that the Fund is trading
at a premium to NAV, unitholders will benefit from reinvesting distributions at
a lower value, generally being NAV. If the Trading Price is lower than the NAV,
such that the Fund is trading at a discount to NAV, unitholders will generally
benefit from reinvesting at below NAV through the acquisition of units in the
market. The DRIP provides an attractive reinvestment mechanism in both
circumstances when the Fund trades at a premium or a discount to NAV. Contact
your investment advisor to enroll in the Fund's DRIP and please visit our
website for complete details of the DRIP plan. 


About Brompton Funds 

Brompton Funds, a division of Brompton Group, is an experienced investment fund
manager operating since 2002. Brompton is focused on meeting the needs of
investors by offering low cost, innovative products with client friendly terms
and supported by strong corporate governance. For further information, please
contact your investment advisor, call Brompton's investor relations line at
416-642-9051, (toll-free at 1-866-642-6001) email info@bromptongroup.com or
visit our website at www.bromptongroup.com. 


Commissions, trailing commissions, management fees and expenses all may be
associated with investment funds. Please read the Fund's publicly filed
documents which are available from SEDAR at www.sedar.com. Investment funds are
not guaranteed, their values change frequently and past performance may not be
repeated. 


Certain statements contained in this news release constitute forward-looking
information within the meaning of Canadian securities laws. Forward-looking
information may relate to matters disclosed in this press release and to other
matters identified in public filings relating to the Fund, to the future outlook
of the Fund and anticipated events or results and may include statements
regarding the future financial performance of the Fund. In some cases,
forward-looking information can be identified by terms such as "may", "will",
"should", "expect", "plan", "anticipate", "believe", "intend", "estimate",
"predict", "potential", "continue" or other similar expressions concerning
matters that are not historical facts. Actual results may vary from such
forward-looking information. Investors should not place undue reliance on
forward-looking statements. These forward-looking statements are made as of the
date hereof and we assume no obligation to update or revise them to reflect new
events or circumstances.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Brompton Funds
Investor Relations
416-642-9051, (toll-free at 1-866-642-6001)
info@bromptongroup.com
www.bromptongroup.com
NAVCO Pharmaceuticals (TSXV:NAV)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more NAVCO Pharmaceuticals Charts.
NAVCO Pharmaceuticals (TSXV:NAV)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more NAVCO Pharmaceuticals Charts.